Missoula Community Health Services, INC.

Missoula Community Health Services, INC. was paid $140K by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	3,440	$15K
2019	3,660	$14K
2020	3,381	$25K
2021	4,915	$9K
2022	4,370	$57K
2023	3,834	$6K
2024incomplete	2,271	$13K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	28%	908	582	$39K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	27%	2,724	2,062	$38K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.5%	1,026	766	$13K
99282	Emergency department visit for the evaluation and management, low to moderate severity	5.8%	1,021	850	$8K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.7%	477	273	$8K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	4.1%	46	43	$6K
80053	Comprehensive metabolic panel	3.4%	3,463	2,699	$5K
96361	Intravenous infusion, hydration; each additional hour	2.6%	81	61	$4K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.6%	1,495	1,254	$4K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.0%	66	56	$3K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.6%	3,515	2,634	$2K
87400		1.1%	264	191	$2K

32 more codes

J3490	Unclassified drugs	1.0%	1,826	$1K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.0%	397	$1K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	160	$1K
36415	Collection of venous blood by venipuncture	<1%	4,357	$919.03
J7030	Infusion, normal saline solution , 1000 cc	<1%	166	$475.11
80061	Lipid panel	<1%	307	$426.02
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	159	$388.47
86140		<1%	355	$335.43
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	322	$292.55
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	19	$232.49
96375	Therapeutic injection; each additional sequential IV push	<1%	66	$209.13
71045	Radiologic examination, chest; single view	<1%	59	$181.92
71046	Radiologic examination, chest; 2 views	<1%	49	$169.87
80048	Basic metabolic panel (calcium, ionized)	<1%	68	$131.99
81001		<1%	263	$117.23
83690		<1%	47	$113.80
84443	Thyroid stimulating hormone (TSH)	<1%	679	$105.24
83036	Hemoglobin; glycosylated (A1C)	<1%	67	$87.87
81003		<1%	347	$59.52
84484		<1%	74	$57.10
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	128	$55.17
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	34	$40.19
90688		<1%	20	$16.20
80305		<1%	19	$6.97
85027		<1%	67	$6.70
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	18	$0.22
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	18	$0.00
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	0%	26	$0.00
81015		0%	60	$0.00
A9270	Non-covered item or service	0%	557	$0.00
87086	Culture, bacterial; quantitative colony count, urine	0%	12	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	39	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCNEECE, JOHN (CEO)